Publikasjoner fra HPV-oppfølgingsprogrammet
Artikkel
|Oppdatert
Samlet oversikt over alle publikasjoner fra det nasjonale oppfølgingsprogrammet.
Feiring B, Laake I, Molden T, Cappelen I, Håberg SE, Magnus P, Steingrímsdóttir ÓA, Strand BH, Stålcrantz J, Trogstad L. Do parental education and income matter? A nationwide register-based study on HPV vaccine uptake in the school-based immunisation pogramme in Norway. BMJ Open 2015 May 19;5(5):e006422.
Molden T, Feiring B, Ambur OH, Christiansen IK, Hansen M, Laake I, et al. Human papillomavirus prevalence and type distribution in urine samples from Norwegian women aged 17 and 21 years: A nationwide cross-sectional study of three non-vaccinated birth cohorts. Papillomavirus Research 2016;2:153-8.
Feiring B, Laake I, Bakken IJ, Greve-Isdahl M, Bruun Wyller V, Håberg S et al. HPV vaccination and risk of chronic fatigue syndrome/myalgic encephalomyelitis: A nationwide register-based study from Norway. Vaccine 2017;35: 4203-4212.
Feiring B, Laake I, Trogstad L. No conflicting results in the article «HPV vaccination and risk of chronic fatigue syndrome/myalgic encephalomyelitis: A nationwide register-based study from Norway». Vaccine 2017;35:7082-7083
Feiring B, Laake I, Christiansen IK, Hansen M, Stålcrantz J, Ambur OH, Magnus P, Jonassen CM, Trogstad L. Substantial decline in prevalence of vaccine-type and non-vaccine type HPV in vaccinated and unvaccinated girls 5 years after implementing HPV vaccine in Norway. Journal of Infectious Diseases 2018; 16. July 2018
Ida Laake, Berit Feiring, Christine Monceyron Jonassen, John H-O Pettersson, Torstein Gjølgali Frengen, Ingerid Ørjansen Kirkeleite & Lill Trogstad. Concurrent Infection With Multiple Human Papillomavirus Types Among Unvaccinated and Vaccinated 17-Year-Old Norwegian Girls. The Journal of Infectious Diseases, 17.november 2020.
Randi Dalene Bjerke, Ida Laake, Berit Feiring, Geir Aamodt & Lill Trogstad. Time trends in HPV vaccination according to country background: a nationwide register-based study among girls in Norway | BMC Public Health | Full Text BMC Public Health volume 21, Article number: 854, 2021.
Allison Portnoy, Kine Pedersen, Lill Trogstad, Bo T. Hansen, Berit Feiring, Ida Laake, Megan A. Smith, Stephen Sy, Mari Nygård, Jane J. Kim, Emily A. Burger. Impact and cost-effectiveness of strategies to accelerate cervical cancer elimination: A model-based analysis .Preventive Medicine, Volume 144, 2021.
Portnoy A, Pedersen K, Trogstad L, Hansen BT, Feiring B, Laake I, Smith MA, Sy S, Nygård M, Kim JJ, Burger EA. Cost-effectiveness of nonavalent HPV vaccine in Norway considering current empirical data and validation. Prev Med. 2021 Sep;150:106688.
Portnoy A, Pedersen K, Nygård M, Trogstad L, Kim JJ, Burger EA. Identifying a Single Optimal Integrated Cervical Cancer Prevention Policy in Norway: A Cost-Effectiveness Analysis. Medical Decision Making. 2022;42(6):795-807.
Portnoy A, Nygård M, Trogstad L, Kim JJ, Burger EA. Impact of Delaying Effective and Cost-Effective Policy Decisions: An Example From Cervical Cancer Prevention in Norway. MDM Policy & Practice. 2022;7(1).
